Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis. [PDF]
Ren FailWu X +5 more
europepmc +1 more source
Risk of intracranial hemorrhage with direct oral anticoagulants: an updated network meta-analysis of randomized controlled trials. [PDF]
Front Cardiovasc MedChen J, Chen Q, Guan C, Xia J.
europepmc +1 more source
Direct Oral Anticoagulant Type and Dose in Atrial Fibrillation With Decompensated Cirrhosis: A Propensity-Matched Analysis. [PDF]
Gastro Hep AdvZanco J +5 more
europepmc +1 more source
Recurrent Pulmonary Embolism After Pulmonary Endarterectomy During Rivaroxaban Therapy in a Resource-Limited Setting. [PDF]
JACC Case RepBatool A, Ansari MI, Lutfi IA, Mohsin M.
europepmc +1 more source
Enhancing immune response in advanced HCC with PVTT: rivaroxaban as a core adjuvant in combined therapy. [PDF]
J Immunother CancerYan Y, Zou D, Li Y, Ma H, Chen H.
europepmc +1 more source
Drug-Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High-Throughput Screening of Clopidogrel and Oral Anticoagulants. [PDF]
Pharmacoepidemiol Drug SafD'Amico AM +9 more
europepmc +1 more source
Direct Oral Anticoagulants Versus Phenprocoumon: Mortality, Thromboembolism and Major Hemorrhage. A Systematic Review and Meta-Analysis of Routine Data Studies. [PDF]
Dtsch Arztebl IntEngelbertz C, Reinecke H, Köppe J.
europepmc +1 more source
The application of low-dose rivaroxaban in elderly patients with atrial fibrillation. [PDF]
Front PharmacolWang Z +7 more
europepmc +1 more source
Clinical profile, management and outcomes of patients taking dual pathway inhibition for cardiovascular protection in clinical practice in Latin America. Data from the XATOA registry. [PDF]
Drugs ContextCornejo-Avendaño JR +8 more
europepmc +1 more source